2m 2m 2m 2m 2m 2m 2m
VIRIDIAN THERAPT (VRDN)
NASDAQ
$30.17+$0.11 (+0.37%)
Price as of Nov 18, 2026 3:40 PM EST- $3.4BMarket Cap
- 5.14%1-Year Change
- BiotechnologyIndustry
VIRIDIAN THERAPT (VRDN)
$30.17+$0.11 (+0.37%)
VRDN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $30.06 | ||
Change | +$0.26 (+0.87%) | ||
Open | $29.72 | ||
High | $30.16 | ||
Low | $29.25 | ||
Previous Close | $29.80 | ||
Volume | 1,838,169 | ||
30-Day Average Volume | 2,803,674 | ||
1-Week Change | -2.59% | ||
1-Month Change | 57.96% | ||
1-Year Change | 5.14% | ||
3-Year Change | 89.29% | ||
5-Year Change | 58.21% | ||
Fundamentals | |||
Shares Outstanding | 113.6M | ||
Total Assets | $1.0B | ||
Market Cap | $3.4B | ||
Enterprise Value | $3.6B | ||
Period: QTR TTM FY | |||
Revenue | $24.7M | ||
Net Income | -$101.2M | ||
Free Cash Flow | -$93.1M | ||
EBIT | -$99.8M | ||
EBITDA | -$99.5M | ||
Net Working Capital | $943.1M | ||
EPS | -$0.81 | ||
Enterprise Value/EBITDA | -36 | ||
Enterprise Value/Revenue | 146 | ||
P/B | 6 | ||
P/E | -37 | ||
PEG | -2 | ||
Price/Free Cash Flow | -37 | ||
Price/Operating Cash Flow | -37 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 11/13/2020 | ||
Earnings & Revenue